BCAL Diagnostics Limited Banner Image

BCAL Diagnostics Limited

  • Ticker BDX
    Exchange ASX More
  • Industry --None-- More
  • Sector Healthcare More
BCAL Diagnostics Limited Logo Image
  • 11-50 Employees
  • Based in Sydney, Australia
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellularMore vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
4.8 / 5.0 (45)

BCAL Diagnostics Limited reports have an aggregate usefulness score of 4.8 based on 45 reviews.

BCAL Diagnostics Limited

Most Recent Annual Report

BCAL Diagnostics Limited
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

BCAL Diagnostics Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!